Best’s News & Research Service subscription required - September 08, 2025 02:19 PM (EDT)
Although GLP-1 weight loss drugs are drawing attention due to quick uptake and high costs, the impact on health insurers' spending was limited due to manufacturer rebates, according to a study . . .
-- This content requires a subscription --
Log in Register your purchase
A subscription includes:
Subscribe
Delaware Health Insurance Health Insurers Pharmaceutical Manufacturers Prescription Drugs Costs Rebating
Reprints & Redistribution
More from Best’s News